These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15143997)

  • 1. [January 2004: a month of success with oxaliplatin and hope for patients with colorectal cancer].
    Tumori; 2004; 90(1):suppl 28-30. PubMed ID: 15143997
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA evaluating oxaliplatin for advanced colorectal cancer treatment.
    Baldwin J
    J Natl Cancer Inst; 2002 Aug; 94(16):1191-3. PubMed ID: 12189219
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adjuvant chemotherapy for colorectal carcinoma].
    Schallhorn A
    Internist (Berl); 2000 Apr; 41(4):387-8. PubMed ID: 10798189
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxaliplatin (Eloxatin) for advanced colon cancer.
    Med Lett Drugs Ther; 2003 Jan; 45(1148):7-8. PubMed ID: 12571541
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxaliplatin: a welcome addition to our therapeutic armamentarium.
    Chu E
    Clin Colorectal Cancer; 2002 Aug; 2(2):72. PubMed ID: 12453318
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxaliplatin in the treatment of colorectal cancer.
    Kim GP; Erlichman C
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):281-94. PubMed ID: 17428157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin for colorectal cancer in the United States: better late than never.
    Chau I; Cunningham D
    J Clin Oncol; 2003 Jun; 21(11):2049-51. PubMed ID: 12775727
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimizing oxaliplatin-based therapy in metastatic colorectal cancer.
    Cassidy J
    Clin Adv Hematol Oncol; 2008 May; 6(5):360-1. PubMed ID: 18516025
    [No Abstract]   [Full Text] [Related]  

  • 9. The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer.
    Malik Z; Eng C
    Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):4-7. PubMed ID: 17491584
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gleaning from the American Oncology Congress. A new standard in colorectal carcinoma].
    MMW Fortschr Med; 2002 Oct; 144(41):61. PubMed ID: 12474374
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxaliplatin for the treatment of advanced colorectal cancer: future directions.
    Ducreux M; Louvet C; Bekradda M; Cvitkovic E
    Semin Oncol; 1998 Apr; 25(2 Suppl 5):47-53. PubMed ID: 9609108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oxaliplatin in colorectal cancer].
    Boni C; Banzi M
    Tumori; 2001; 87(1 Suppl 1):S51-2. PubMed ID: 11300025
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oxaliplatin].
    Bascioni R
    Suppl Tumori; 2004; 3(4):S111-2. PubMed ID: 15206232
    [No Abstract]   [Full Text] [Related]  

  • 14. Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Pro: The CapeOx regimen is preferred over FOLFOX.
    Chang DZ; Abbruzzese JL
    Clin Adv Hematol Oncol; 2005 May; 3(5):400-4. PubMed ID: 16167013
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advances in the treatment of metastatic colorectal cancer with bevacizumab].
    Longo F; Mansueto G
    Tumori; 2006; 92(5):suppl 1-12. PubMed ID: 17168449
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent data with oxaliplatin-containing regimens in the adjuvant treatment of colorectal cancer.
    Reddy GK
    Clin Colorectal Cancer; 2005 Jul; 5(2):83-5. PubMed ID: 16098247
    [No Abstract]   [Full Text] [Related]  

  • 17. [ASCO 2005: Progression with oxaliplatin in the treatment of colorectal neoplasms].
    Longo F; Mansueto G
    Tumori; 2005; 91(3):suppl 1-12. PubMed ID: 16206661
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxaliplatin in colorectal cancer: an overview.
    Armand JP; Boige V; Raymond E; Fizazi K; Faivre S; Ducreux M
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):96-104. PubMed ID: 11049040
    [No Abstract]   [Full Text] [Related]  

  • 19. Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963).
    Innominato PF; Giacchetti S; Moreau T; Smaaland R; Focan C; Bjarnason GA; Garufi C; Iacobelli S; Tampellini M; Tumolo S; Carvalho C; Karaboué A; Lévi F;
    Chronobiol Int; 2011 Aug; 28(7):586-600. PubMed ID: 21859417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irinotecan or oxaliplatin combined with 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer: a meta-analysis.
    Liang XB; Hou SH; Li YP; Wang LC; Zhang X; Yang J
    Chin Med J (Engl); 2010 Nov; 123(22):3314-8. PubMed ID: 21163137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.